GENOME LINK

Berkeley, United States Founded: 2017 • Age: 9 yrs
DNA data is stored and interpreted through an online platform.

About GENOME LINK

GENOME LINK is a company based in Berkeley (United States) founded in 2017 by Yuta Matsuda, Kensuke Numakura, and Tomohiro Takano. GENOME LINK has raised $225 thousand across 3 funding rounds from investors including Berkeley SkyDeck, m3.com and Y Combinator. The company has 4 employees. GENOME LINK offers products and services including DNA Analysis Platform, Ancestry Reports, and Wellness Reports. GENOME LINK operates in a competitive market with competitors including Viome, Invitae, Helix, Color and Everlywell, among others.

  • Headquarter Berkeley, United States
  • Employees 4
  • Founders Yuta Matsuda, Kensuke Numakura, Tomohiro Takano
  • Sectors
    Healthcare
  • Website category Hobbies and Leisure · Ancestry and Genealogy
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website genomelink.io
  • Social X Facebook Instagram
  • Legal Name Genomelink, Inc.
Key Metrics
  • Total Equity Funding
    $225K (USD)

    in 3 rounds

  • Latest Funding Round
    $125K (USD), Seed

    Sep 2021

  • Investors
  • Employee Count
    4

Products & Services of GENOME LINK

GENOME LINK offers a comprehensive portfolio of products and services, including DNA Analysis Platform, Ancestry Reports, and Wellness Reports.

DNA Analysis Platform
Genetic Services

Platform for uploading DNA data to generate trait reports

Ancestry Reports
Ancestry Analysis

Reports on ethnic and ancient heritage from DNA data

Wellness Reports
Health Insights

DNA-based advice on nutrition, fitness, and mental health

Funding Insights of GENOME LINK

GENOME LINK has successfully raised a total of $225K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $225,000
  • Total Rounds 3
  • Last Round Seed β€” $125,000
  • Investors Count 5

All 3 funding rounds of GENOME LINK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2021$125,000Seed–Y Combinator
–
Dec 2017$100,000Seed–Berkeley SkyDeck
–
Aug 2017–Seed–500 Startups Japan
Valuation history

5 investors in total: 5 institutional.

Investors in GENOME LINK

GENOME LINK has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Berkeley SkyDeck, m3.com and Y Combinator.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage startups are accelerated via funding and educational programs.
–ycombinator.comMountain View, United States
Startups are accelerated and incubated across diverse industries.
2012skydeck.berkeley.eduBerkeley, United States
Startup growth and funding support are provided by EXPACT.
2018500startups.jpShizuoka, Japan
Japan's members-only networking site for healthcare professionals is operated.
2000m3.comTokyo, Japan
Sanamedi is engaged in medical device development consulting.
–jomdd.comJapan
Premium access

Investor details for GENOME LINK

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of GENOME LINK

22 people are tracked at GENOME LINK (5 in leadership, 7 in board & advisors, 10 in team); the tracked headcount is 4.

NameRoleGroup
Yuta Matsuda
Co-Founder & COOLeadership
Kensuke Numakura
Co-Founder & CTOLeadership
Tomohiro Takano
Co-Founder & CEOLeadership
Taj Walton
Head, ProductLeadership
Akiko Yoshida
B2c Marketing Research At The Ceo's OfficeLeadership
Seth Bindernagel
Advisor & InvestorBoard & advisors
Carlos Bustamante
Head of Science AdvisoryBoard & advisors
Tomy Kamada
Advisor & InvestorBoard & advisors
Hiroaki Kitano
Advisor & InvestorBoard & advisors
Mya Thomae
Advisor & InvestorBoard & advisors
Andreas Stahl
AdvisorBoard & advisors
D.a. Wallach
Advisor & InvestorBoard & advisors
Kate Mironenko
Software EngineerTeam
David Kravitz
Product ManagerTeam
Artem Chumak
Software EngineerTeam
Nacho Urpi
Software EngineerTeam
Sabrina Miller
Software EngineerTeam
Stas Kulesh
DesignerTeam
Alya Yuzgina
DesignerTeam
Vlad Sadovenko
CX DesignerTeam

2 more people are available in the full profile.

Premium access

Complete people profiles for GENOME LINK

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of GENOME LINK

3 dated milestones of GENOME LINK across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded GENOME LINK is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed, of $125K.

Competitors of GENOME LINK

GENOME LINK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Helix, Color and Everlywell, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viome.com2016Los Alamos, United States$301.57M136
Machine learning-based bioinformatics solutions for health insights are provided.
invitae.com2010San Francisco, United States$189.56M1,700
Home-based genetic tests for detecting diseases are provided to individuals.
helix.com2015San Francisco, United States$435M–
Genomic database for clinical research is provided.
color.com2013Burlingame, United States$506.44M687
Cancer care is delivered through a virtual clinic by Color.
everlywell.com2014Austin, United States$330M614
At-home health tests for biomarkers, nutrition, and hormone analysis.
variantbio.com2018Brooklyn, United States$127.74M–
Personalized therapeutics are developed using genomic data for rare diseases.
newtopia.com2008New York, United States$13.1M–
Health management platform is provided for employers and insurers.
counsyl.com2007San Francisco, United States$112.89M503
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
digbihealth.com2018Mountain View, United States$5.4M–
Personalized healthcare is delivered through DNA and gut biome testing.
goodstartgenetics.com2008Boston, United States$32.16M–
Molecular diagnostics for inherited genetic disease screening are provided.
Premium access

Detailed competitors of GENOME LINK

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of GENOME LINK

The website of GENOME LINK (genomelink.io) receives about 1M visits a month and ranks #39,195 among all websites worldwide, #233 in Ancestry and Genealogy.

  • Monthly visits
    1M

    ▼ 2.6% vs previous month

  • Unique visitors
    397.5K

    per month

  • Global rank
    #39,195

    among all websites

  • Category rank
    #233

    Hobbies and Leisure · Ancestry and Genealogy

Similar websites

Websites whose visitors overlap most with GENOME LINK. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
myheritage.com
100%
12.2M#2,869View details
mytrueancestry.com
mytrueancestry.com
89%
–#155,002–
familytreedna.com
88%
–#34,420View details
23andme.com
88%
4.4M#8,883View details
ancestry.com
86%
37.5M#497View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 29 similar websites and full traffic analytics for GENOME LINK

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 29 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to GENOME LINK

10 companies that operate in the same segment as GENOME LINK (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about GENOME LINK

GENOME LINK was founded in 2017.

GENOME LINK is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Tomohiro Takano is the current CEO of GENOME LINK. They have also founded this company.

GENOME LINK is a funded company, having raised a total of $225K across 3 funding rounds to date.

GENOME LINK has 4 employees.

Genome Link was founded in 2017 in Berkeley, United States, as a provider in the genomics sector. An online platform is operated to store DNA data obtained from services such as 23andMe, Ancestry.com, and MyHeritage. Tools are offered for visualizing this data and deriving insights on ancestry, body traits, intelligence, and aptitudes, supporting user analysis in personal genomics.

GENOME LINK's top competitors include Viome, Helix and Variant Bio.

GENOME LINK offers DNA Analysis Platform, Ancestry Reports, and Wellness Reports.

GENOME LINK has 5 investors. Key investors include Berkeley SkyDeck, m3.com, Y Combinator, EXPACT, and Sanamedi.

GENOME LINK operates through Genomelink, Inc..

The website of GENOME LINK receives about 1 million visits a month and ranks #39,195 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available